Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-01 to 2024-02-02
Current total value of award: $1487.7
Description: 4563653355!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML